voriconazole has been researched along with Hallucination of Body Sensation in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Buclin, T; Haefliger, D; Lamoth, F; Livio, F; Marzolini, C; Pabst, T | 1 |
| Cheng, JH; Huang, LP; Jiang, C; Jiang, YK; Que, CX; Wang, RY; Wang, X; Yip, CW; Zhao, HZ; Zhou, LH; Zhu, LP | 1 |
| Asano, S; Kato, K; Sakurada, H; Tachi, T; Teramachi, H; Yamamura, M; Yasuhara, K; Yoshida, M | 1 |
| Hagihara, M; Hamada, Y; Kato, H; Koizumi, Y; Matsuura, K; Mikamo, H; Nishiyama, N; Yamagishi, Y | 1 |
| Bennett, JE; Childs, R; Murayama, N; Natarajan, V; Palmore, T; Skinner, J; Yamazaki, H; Zonios, D | 1 |
| Liu, P; Mould, DR | 1 |
| Akbayram, S; Bayhan, GI; Garipardic, M; Karaman, K | 1 |
| Imataki, O; Ishida, T; Kitanaka, A; Kubota, Y; Ohnishi, H; Tanaka, T | 1 |
| Bearman, G; Pakyz, A | 1 |
| Pea, F; Viale, P | 1 |
| Aguado, JM; Fernández-Ruiz, M; Gutiérrez, E; López-Medrano, F | 1 |
| Booth, DR; Liddle, C; O'Connor, K; Stewart, GJ; Suan, D | 1 |
| Agrawal, AK; Sherman, LK | 1 |
| Fernández Ballesteros, A; Flox Benítez, G; Quero Escalada, M; Rondón Fernández, P | 1 |
| Imhof, A; Schaer, DJ; Schanz, U; Schwarz, U | 1 |
| Bennett, JE; Childs, R; Gea-Banacloche, J; Zonios, DI | 1 |
16 other study(ies) available for voriconazole and Hallucination of Body Sensation
| Article | Year |
|---|---|
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole.
Topics: Antifungal Agents; Drug Interactions; Female; Hallucinations; Humans; Leukemia, Myeloid, Acute; Middle Aged; Voriconazole | 2023 |
Genetic polymorphisms of transient receptor potential melastatin 1 correlate with voriconazole-related visual adverse events.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Genotype; Hallucinations; Humans; Invasive Fungal Infections; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; TRPM Cation Channels; Voriconazole; Young Adult | 2020 |
An investigation of visual hallucinations associated with voriconazole administration to patients with hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hallucinations; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Vision Disorders; Voriconazole | 2016 |
Visual disturbance or central symptom like hallucination in patients treated voriconazole: report of six cases.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Hallucinations; Humans; Male; Vision Disorders; Voriconazole | 2016 |
Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Female; Hallucinations; Homozygote; Humans; Liver; Male; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2014 |
Population pharmacokinetic-pharmacodynamic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Chemical and Drug Induced Liver Injury; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Hallucinations; Humans; Male; Middle Aged; Models, Statistical; Photophobia; Prospective Studies; Voriconazole | 2014 |
Voriconazole-associated visual disturbances and hallucinations.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Female; Hallucinations; Humans; Vision Disorders; Voriconazole | 2016 |
Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hallucinations; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
Topics: Antifungal Agents; Drug Monitoring; Hallucinations; Humans; Neurotoxicity Syndromes; Pyrimidines; Risk Assessment; Triazoles; Voriconazole | 2009 |
[Complex visual hallucinations induced by voriconazole].
Topics: Aged; Antifungal Agents; Female; Hallucinations; Humans; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole toxicity related to polymorphisms in CYP2C19.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Hallucinations; Humans; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole-induced musical hallucinations.
Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
[Hallucinosis as side effect of voriconazole].
Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2005 |
Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.
Topics: Adult; Antifungal Agents; Asthenia; Cognition Disorders; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hallucinations; Humans; Irritable Mood; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Triazoles; Vision Disorders; Voriconazole | 2006 |
Hallucinations during voriconazole therapy.
Topics: Adolescent; Adult; Aged; Female; Hallucinations; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |